Market Insights Health Pharmacies OTC Products

Hand Sanitizer (Pharmacies) - EU-27

EU-27

Revenue in the Hand Sanitizer market is projected to reach US$296.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.75%, resulting in a market volume of US$339.50m by 2029.
In global comparison, most revenue will be generated in China (US$385.20m in 2024).
In relation to total population figures, per person revenues of US$0.66 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in EU-27 is experiencing steady growth due to increasing customer preferences for personal hygiene and the local special circumstances surrounding health and safety concerns.

Customer preferences: Customer preferences for personal hygiene have been a driving factor in the growth of the Hand Sanitizer (Pharmacies) market in EU-27. With the rise of infectious diseases and the importance of hand hygiene in preventing their spread, consumers are increasingly seeking out hand sanitizers as a convenient and effective way to clean their hands on the go. This preference for hand sanitizers is further fueled by the ease of use and portability of these products, making them a popular choice among busy individuals who are constantly on the move.

Trends in the market: The Hand Sanitizer (Pharmacies) market in EU-27 is witnessing several key trends. Firstly, there is a growing demand for natural and organic hand sanitizers, as consumers become more conscious of the ingredients used in their personal care products. This trend is driven by a desire for products that are free from harsh chemicals and potentially harmful additives. Another trend in the market is the increasing popularity of hand sanitizers with moisturizing properties. As frequent use of hand sanitizers can sometimes lead to dry and irritated skin, consumers are seeking out products that not only sanitize but also nourish and protect their hands. This trend is particularly prevalent in regions with colder climates, where dry skin is a common issue.

Local special circumstances: The local special circumstances surrounding health and safety concerns have also contributed to the growth of the Hand Sanitizer (Pharmacies) market in EU-27. The COVID-19 pandemic has significantly increased awareness about the importance of hand hygiene, leading to a surge in demand for hand sanitizers. Governments and health authorities have also implemented strict guidelines and regulations regarding hand hygiene in public spaces, further driving the need for hand sanitizers.

Underlying macroeconomic factors: The underlying macroeconomic factors in the EU-27, such as population growth, increasing disposable income, and urbanization, are also contributing to the growth of the Hand Sanitizer (Pharmacies) market. As the population continues to grow and more people move to urban areas, the demand for convenient and portable personal care products like hand sanitizers is expected to increase. Additionally, rising disposable income levels enable consumers to prioritize their health and hygiene, leading to higher spending on products like hand sanitizers. In conclusion, the Hand Sanitizer (Pharmacies) market in EU-27 is growing due to increasing customer preferences for personal hygiene, the local special circumstances surrounding health and safety concerns, and underlying macroeconomic factors. The market is witnessing trends such as the demand for natural and organic hand sanitizers and the popularity of moisturizing hand sanitizers. With the ongoing emphasis on hand hygiene and the convenience of hand sanitizers, the market is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.